Filing Details
- Accession Number:
- 0001127602-12-026197
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-09-12 14:23:56
- Reporting Period:
- 2012-09-11
- Filing Date:
- 2012-09-12
- Accepted Time:
- 2012-09-12 14:23:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
799729 | Parexel International Corp | PRXL | Services-Commercial Physical & Biological Research (8731) | 042776269 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1266051 | J Christopher Lindop | Haemonetics Corporation 400 Wood Road Braintree MA 02184-9114 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-09-11 | 7,800 | $30.10 | 40,355 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the reporting person.
- This transaction was executed in multiple trades through a trade order executed by a broker-dealer at prices ranging from $29.97- $30.23. The price reported in this column reflects the weighted average sale price. For all transactions reported on this Form 4 utilizing a weighted average sale price, the reporting person will provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price.